Patients can benefit both financially and clinically by enrolling in ongoing clinical trials, said Eric Lander, MD.

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

Widespread noncompliance with federal cost-sharing rules exists, particularly impacting Medicare beneficiaries and ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

It's a critical time to spotlight the dire health disparities affecting Black Americans, from premature deaths to maternal ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

A report reveals that 45% of insured adults received unexpected medical bills for services they believed were covered.

FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

Patients were stratified into 4 risk groups based on recent heart failure hospitalization (HFH) and use of loop diuretics. 1 ...